These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25376228)

  • 21. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
    De Boeck K; Weren M; Proesmans M; Kerem E
    Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Faecal calprotectin, lactoferrin, M2-pyruvate kinase and S100A12 in severe ulcerative colitis: a prospective multicentre comparison of predicting outcomes and monitoring response.
    Turner D; Leach ST; Mack D; Uusoue K; McLernon R; Hyams J; Leleiko N; Walters TD; Crandall W; Markowitz J; Otley AR; Griffiths AM; Day AS
    Gut; 2010 Sep; 59(9):1207-12. PubMed ID: 20801771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High level of fecal calprotectin at age 2 months as a marker of intestinal inflammation predicts atopic dermatitis and asthma by age 6.
    Orivuori L; Mustonen K; de Goffau MC; Hakala S; Paasela M; Roduit C; Dalphin JC; Genuneit J; Lauener R; Riedler J; Weber J; von Mutius E; Pekkanen J; Harmsen HJM; Vaarala O;
    Clin Exp Allergy; 2015 May; 45(5):928-939. PubMed ID: 25758537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age-related faecal calprotectin, lactoferrin and tumour M2-PK concentrations in healthy volunteers.
    Joshi S; Lewis SJ; Creanor S; Ayling RM
    Ann Clin Biochem; 2010 May; 47(Pt 3):259-63. PubMed ID: 19740914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abdominal Symptoms Assessed With the CFAbd-Score are Associated With Intestinal Inflammation in Patients With Cystic Fibrosis.
    Jaudszus A; Pfeifer E; Lorenz M; Beiersdorf N; Hipler UC; Zagoya C; Mainz JG
    J Pediatr Gastroenterol Nutr; 2022 Mar; 74(3):355-360. PubMed ID: 34789668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High faecal calprotectin levels in intestinal tuberculosis are associated with granulomas in intestinal biopsies.
    Larsson G; Shenoy KT; Ramasubramanian R; Thayumanavan L; Balakumaran LK; Bjune GA; Moum BA
    Infect Dis (Lond); 2015 Mar; 47(3):137-43. PubMed ID: 25522183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration.
    Bruzzese E; Raia V; Gaudiello G; Polito G; Buccigrossi V; Formicola V; Guarino A
    Aliment Pharmacol Ther; 2004 Oct; 20(7):813-9. PubMed ID: 15379842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fecal calprotectin as a correlative marker in clinical severity of infectious diarrhea and usefulness in evaluating bacterial or viral pathogens in children.
    Chen CC; Huang JL; Chang CJ; Kong MS
    J Pediatr Gastroenterol Nutr; 2012 Nov; 55(5):541-7. PubMed ID: 22699836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic accuracy of fecal elastase 1 assay in patients with pancreatic maldigestion or intestinal malabsorption: a collaborative study of the Italian Society of Pediatric Gastroenterology and Hepatology.
    Carroccio A; Verghi F; Santini B; Lucidi V; Iacono G; Cavataio F; Soresi M; Ansaldi N; Castro M; Montalto G
    Dig Dis Sci; 2001 Jun; 46(6):1335-42. PubMed ID: 11414313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fecal calprotectin concentrations in alcoholic patients: a longitudinal study.
    Montalto M; Gallo A; Ferrulli A; Visca D; Campobasso E; Cardone S; D'Onofrio F; Santoro L; Covino M; Mirijello A; Leggio L; Gasbarrini G; Addolorato G
    Eur J Gastroenterol Hepatol; 2011 Jan; 23(1):76-80. PubMed ID: 21030869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms.
    Kotze LM; Nisihara RM; Marion SB; Cavassani MF; Kotze PG
    Arq Gastroenterol; 2015; 52(1):50-4. PubMed ID: 26017083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal antibody testing for fecal calprotectin is superior to polyclonal testing of fecal calprotectin and lactoferrin to identify organic intestinal disease in patients with abdominal discomfort.
    Burri E; Manz M; Rothen C; Rossi L; Beglinger C; Lehmann FS
    Clin Chim Acta; 2013 Feb; 416():41-7. PubMed ID: 23178549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Usefulness of a Novel Screening Kit for Colorectal Cancer Using the Immunochromatographic Fecal Tumor M2 Pyruvate Kinase Test.
    Kim YC; Kim JH; Cheung DY; Kim TH; Jun EJ; Oh JW; Kim CW; Chung WC; Kim BW; Kim SS; Kim JI; Park SH; Kim JK
    Gut Liver; 2015 Sep; 9(5):641-8. PubMed ID: 25473070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fecal M2-PK in children with Crohn's disease: a preliminary report.
    Day AS; Judd T; Lemberg DA; Leach ST
    Dig Dis Sci; 2012 Aug; 57(8):2166-70. PubMed ID: 22736014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease.
    Kolho KL; Raivio T; Lindahl H; Savilahti E
    Scand J Gastroenterol; 2006 Jun; 41(6):720-5. PubMed ID: 16716972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fecal calprotectin concentrations are higher in exclusively breastfed infants compared to those who are mixed-fed.
    Dorosko SM; Mackenzie T; Connor RI
    Breastfeed Med; 2008 Jun; 3(2):117-9. PubMed ID: 18564000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fecal calprotectin concentration in children affected by SIBO.
    Fundarò C; Fantacci C; Ansuini V; Giorgio V; Filoni S; Barbaro F; Gasbarrini A; Rossi C
    Eur Rev Med Pharmacol Sci; 2011 Nov; 15(11):1328-35. PubMed ID: 22195368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gut Microbiota in Children With Cystic Fibrosis: A Taxonomic and Functional Dysbiosis.
    Coffey MJ; Nielsen S; Wemheuer B; Kaakoush NO; Garg M; Needham B; Pickford R; Jaffe A; Thomas T; Ooi CY
    Sci Rep; 2019 Dec; 9(1):18593. PubMed ID: 31819107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term evaluation of faecal calprotectin levels in a European cohort of children with cystic fibrosis.
    Roca M; Masip E; Colombo C; Boon M; Hulst JM; Garriga M; de Koning BAE; Bulfamante A; de Boeck K; Ribes-Koninckx C; Calvo-Lerma J
    Arch Dis Child; 2024 Jun; 109(7):552-556. PubMed ID: 38123920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fecal calprotectin: cutoff values for identifying intestinal distress in preterm infants.
    Campeotto F; Baldassarre M; Butel MJ; Viallon V; Nganzali F; Soulaines P; Kalach N; Lapillonne A; Laforgia N; Moriette G; Dupont C; Kapel N
    J Pediatr Gastroenterol Nutr; 2009 Apr; 48(4):507-10. PubMed ID: 19322064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.